>
Switch to:

Turning Point Therapeutics Return-on-Tangible-Asset

: -12.54% (As of Mar. 2021)
View and export this data going back to 2019. Start your Free Trial

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Turning Point Therapeutics's annualized Net Income for the quarter that ended in Mar. 2021 was $-142.02 Mil. Turning Point Therapeutics's average total tangible assets for the quarter that ended in Mar. 2021 was $1,132.15 Mil. Therefore, Turning Point Therapeutics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2021 was -12.54%.

NAS:TPTX' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -36.14   Med: -30.34   Max: -16.07
Current: -16.07

-36.14
-16.07

During the past 4 years, Turning Point Therapeutics's highest Return-on-Tangible-Asset was -16.07%. The lowest was -36.14%. And the median was -30.34%.

NAS:TPTX's Return-on-Tangible-Asset is ranked higher than
64% of the 1368 Companies
in the Biotechnology industry.

( Industry Median: -38.42 vs. NAS:TPTX: -16.07 )

Turning Point Therapeutics Return-on-Tangible-Asset Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
Return-on-Tangible-Asset -36.14 -33.23 -27.45 -20.18

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Return-on-Tangible-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.34 -22.46 -9.77 -20.36 -12.54

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Turning Point Therapeutics Return-on-Tangible-Asset Distribution

* The bar in red indicates where Turning Point Therapeutics's Return-on-Tangible-Asset falls into.



Turning Point Therapeutics Return-on-Tangible-Asset Calculation

Turning Point Therapeutics's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2020 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2020 )  (A: Dec. 2019 )(A: Dec. 2020 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2020 )  (A: Dec. 2019 )(A: Dec. 2020 )
=-157.292/( (422.202+1136.713)/ 2 )
=-157.292/779.4575
=-20.18 %

Turning Point Therapeutics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2021 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2021 )  (Q: Dec. 2020 )(Q: Mar. 2021 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2021 )  (Q: Dec. 2020 )(Q: Mar. 2021 )
=-142.016/( (1136.713+1127.584)/ 2 )
=-142.016/1132.1485
=-12.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2021) net income data.


Turning Point Therapeutics  (NAS:TPTX) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Turning Point Therapeutics Return-on-Tangible-Asset Related Terms


Turning Point Therapeutics Return-on-Tangible-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)